Trial · NCT01111838
Clinical and Translational Study of STA-9090
NCT01111838, Phase 2, Completed, Memorial Sloan Kettering Cancer Center; results first posted 2015-11-20
3 sourcestrials-2026-11-12-0.4.0
Cite this record
ConductScience Library. Clinical and Translational Study of STA-9090. Trials, record NCT01111838. Release trials-2026-11-12-0.4.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT01111838
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
- Clinical and Translational Study of STA-9090
- NCT number
- NCT01111838
- Status
- Completed
- Phases
- Phase 2
- Enrollment
- 20 participants, actual
- Lead sponsor
- Memorial Sloan Kettering Cancer Center
- Conditions
- Colon Cancer, Rectal Cancer
- Interventions
- STA-9090
- First posted
- 2010-04-28
- Last updated
- 2015-11-20
- Results first posted
- 2015-11-20
Source ClinicalTrials.gov
Registered outcomes1
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | To Determine Overall Objective Response. | every 8 weeks | Patients with measurable disease will be evaluated using RECIST criteria for determination of response. |
Source ClinicalTrials.gov
Outcomes1
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
| Type | Outcome | Time frame | Population | Units | Measured as |
|---|---|---|---|---|---|
| PRIMARY | To Determine Overall Objective Response. | every 8 weeks | participants | NUMBER |
Source ClinicalTrials.gov
Results by group2
Each measurement the trial posted, group by group, in the words and numbers it posted.
| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| To Determine Overall Objective Response. | Patients With Refractory Metastatic Colorectal Cancer | Progression of Disease (POD) | 9 | participants | |
| To Determine Overall Objective Response. | Patients With Refractory Metastatic Colorectal Cancer | Stable Disease (SD) | 6 | participants |
Source ClinicalTrials.gov
Participant flow3
How many started, completed or left each group, period by period.
| Period | Milestone | Group | Participants | Units counted |
|---|---|---|---|---|
| Overall Study | STARTED | Patients With Refractory Metastatic Colorectal Cancer | 22 | |
| Overall Study | COMPLETED | Patients With Refractory Metastatic Colorectal Cancer | 15 | |
| Overall Study | NOT COMPLETED | Patients With Refractory Metastatic Colorectal Cancer | 7 |
Source ClinicalTrials.gov
Adverse events51
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
| Type | Event | Organ system | Group | Affected | At risk | Events |
|---|---|---|---|---|---|---|
| other | ALT, SGPT | Blood and lymphatic system disorders | Patients With Refractory Metastatic Colorectal Cancer | 7 | 15 | 7 |
| other | AST, SGOT | Blood and lymphatic system disorders | Patients With Refractory Metastatic Colorectal Cancer | 9 | 15 | 9 |
| other | Albumin, low (hypoalbuminemia) | Metabolism and nutrition disorders | Patients With Refractory Metastatic Colorectal Cancer | 6 | 15 | 6 |
| other | Alkaline phosphatase | Metabolism and nutrition disorders | Patients With Refractory Metastatic Colorectal Cancer | 10 | 15 | 10 |
| other | Allergy reaction (including drug fever) | General disorders | Patients With Refractory Metastatic Colorectal Cancer | 1 | 15 | 2 |
| other | Amylase | Blood and lymphatic system disorders | Patients With Refractory Metastatic Colorectal Cancer | 4 | 15 | 4 |
| other | Anorexia | Psychiatric disorders | Patients With Refractory Metastatic Colorectal Cancer | 3 | 15 | 4 |
| other | Ascites (non-malignant) | General disorders | Patients With Refractory Metastatic Colorectal Cancer | 1 | 15 | 1 |
| other | Bilirubin (hyperbilirubinemia) | Metabolism and nutrition disorders | Patients With Refractory Metastatic Colorectal Cancer | 6 | 15 | 6 |
| other | CPK (creatine phosphokinase) | Metabolism and nutrition disorders | Patients With Refractory Metastatic Colorectal Cancer | 1 | 15 | 1 |
1 to 10 of 51Source ClinicalTrials.gov
See all 51 adverse eventsAdverse event totals3
The totals the trial posted for each group.
| Total | Group | Affected | At risk |
|---|---|---|---|
| Total, all-cause mortality | Patients With Refractory Metastatic Colorectal Cancer | ||
| Total, other adverse events | Patients With Refractory Metastatic Colorectal Cancer | 10 | 15 |
| Total, serious adverse events | Patients With Refractory Metastatic Colorectal Cancer | 7 | 15 |
Source ClinicalTrials.gov
Papers0
The papers the trial lists on ClinicalTrials.gov.
None in this release.
Grants0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
None in this release.
Trial comparisons0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
None in this release.
Tests0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
None in this release.
Data dates
The day each source was copied for this release.
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT01111838
GET https://conductscience.org/api/trials/v1/NCT01111838/events?page=2